Allergy market set for consolidation says Stallergenes' Managing director
This article was originally published in Scrip
Executive Summary
The managing director of one of the largest allergy-focused companies, Stallergenes based in Paris, has predicted widespread consolidation in the area in the near future. Dr Louis Champion explained his theory to Scrip and told of how his company might take advantage of opportunities in the market.